Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
American Journal of Obstetrics & Gynecology MFM|January 16, 2021
Vascular endothelial mitochondrial oxidative stress in response to preeclampsia: a role for angiotension II type 1 autoantibodiesEvangeline Deer, V Ramana Vaka, Kristen M McMaster, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 3, 2021
Progesterone-induced blocking factor improves blood pressure, inflammation, and pup weight in response to reduced uterine perfusion pressure (RUPP)Jesse N Cottrell, Alexis C Witcher, Kyleigh Comley, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 22, 2012
IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancyPushpinder Dhillion, Kedra Wallace, Florian Herse, et al.
Pregnancy Hypertension|September 27, 2020
17-Hydroxyprogesterone caproate improves hypertension and renal endothelin-1 in response to sFlt-1 induced hypertension in pregnant ratsLorena M Amaral, Jesse N Cottrell, Kyleigh M Comley, et al.
Clinical Science (London, England : 1979)|October 19, 2017
Natural killer cells mediate pathophysiology in response to reduced uterine perfusion pressureJamil Elfarra, Lorena M Amaral, Maggie McCalmon, et al.
Pregnancy Hypertension|December 7, 2019
17-Hydroxyprogesterone caproate improves T cells and NK cells in response to placental ischemia; new mechanisms of action for an old drugJamil T Elfarra, Jesse N Cottrell, Denise C Cornelius, et al.
Hypertension in Pregnancy|May 22, 2015
IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsiaAshlyn Harmon, Denise Cornelius, Lorena Amaral, et al.
Cells|November 27, 2021
Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during PregnancyEvangeline Deer, Jalisa Jones, Denise C Cornelius, et al.
Hypertension in Pregnancy|October 29, 2020
Angiotensin II type 1 receptor autoantibody blockade improves cerebral blood flow autoregulation and hypertension in a preclinical model of preeclampsiaJeremy W Duncan, Daniel Azubuike, George W Booz, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 2017
Continued Investigation Into 17-OHPC: Results From the Preclinical RUPP Rat Model of PreeclampsiaLorena M Amaral, Jessica L Faulkner, Jamil Elfarra, et al.
Pageof 11